James Randolph Hunter Jr.
Director · Tonix Pharmaceuticals Holding Corp.
Individual
- 2026
- May 14, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies James Randolph Hunter Jr. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Seth Lederman - $373K in TNXP purchases and sales in the last 12 months
- Richard Newcomb Stillwell - $58K in TNXP purchases and sales in the last 12 months
- Carolyn E. Taylor - $15K in TNXP purchases and sales in the last 12 months
- Richard H. Bagger - $13K in TNXP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is James Randolph Hunter Jr.?
James Randolph Hunter Jr. is a corporate insider, tracked as Director of Tonix Pharmaceuticals Holding Corp. (TNXP). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did James Randolph Hunter Jr. last file a Form 4?
The only primary Form 4 on record is dated 14 May 2026.